Cumulative cohort design for dose-finding

被引:66
作者
Ivanova, Anastasia [1 ]
Flournoy, Nancy
Chung, Yeonseung
机构
[1] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA
[2] Univ Missouri, Dept Stat, Columbia, MO 65211 USA
关键词
phase I clinical trials; group up-and-down designs; toxicity studies; delayed responses; continual reassessment method; Markov chains; maximum tolerated dose; non-parametric designs;
D O I
10.1016/j.jspi.2006.07.009
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
We introduce a new design for dose-finding in the context of toxicity studies for which it is assumed that toxicity increases with dose. The goal is to identify the maximum tolerated dose, which is taken to be the dose associated with a prespecified "target" toxicity rate. The decision to decrease, increase or repeat a dose for the next subject depends on how far an estimated toxicity rate at the current dose is from the target. The size of the window within which the current dose will be repeated is obtained based on the theory of Markov chains as applied to group up-and-down designs. But whereas the treatment allocation rule in Markovian group up-and-down designs is only based on information from the current cohort of subjects, the treatment allocation rule for the proposed design is based on the cumulative information at the current dose. We then consider an extension of this new design for clinical trials in which the subject's outcome is not known immediately. The new design is compared to the continual reassessment method. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:2316 / 2327
页数:12
相关论文
共 30 条
[1]  
[Anonymous], HDB STAT CLIN ONCOLO
[2]  
[Anonymous], METRIKA
[3]  
[Anonymous], 2006, Statistical Methods for Dose-Finding Experiments
[4]  
Barlow R. E., 1972, STAT INFERENCE ORDER
[5]   Up-and-down experiments of first and second order [J].
Bortot, P ;
Giovagnoli, A .
JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2005, 134 (01) :236-253
[6]   How first-time-in-human studies are being performed: A survey of phase I dose-escalation trials in healthy volunteers published between 1995 and 2004 [J].
Buoen, C ;
Bjerrum, OJ ;
Thomsen, MS .
JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (10) :1123-1136
[7]   Sequential designs for phase I clinical trials with late-onset toxicities [J].
Cheung, YK ;
Chappell, R .
BIOMETRICS, 2000, 56 (04) :1177-1182
[8]   Designs for single- or multiple-agent phase I trials [J].
Conaway, MR ;
Dunbar, S ;
Peddada, SD .
BIOMETRICS, 2004, 60 (03) :661-669
[9]   Adaptive designs for dose-finding based on efficacy-toxicity response [J].
Dragalin, V ;
Fedorov, V .
JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2006, 136 (06) :1800-1823
[10]  
Durham SD, 1995, INST MATH S, V25, P139, DOI 10.1214/lnms/1215451483